Cutaneous leiomyomas lack estrogen and progesterone receptor immunoreactivity

被引：19

作者：

McGinley, KM ^{[1
]}

Bryant, S ^{[1
]}

Kattine, AA ^{[1
]}

Fitzgibbon, JF ^{[1
]}

Googe, PB ^{[1
]}

机构：

[1] UNIV TENNESSEE,MED CTR,DEPT PATHOL,DIV DERMATOPATHOL,KNOXVILLE,TN 37920

来源：

JOURNAL OF CUTANEOUS PATHOLOGY | 1997年 / 24卷 / 04期

关键词：

D O I：

10.1111/j.1600-0560.1997.tb01588.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Gonadotropin-releasing hormone analog therapy is useful in treating uterine and some extrauterine smooth muscle tumors. These smooth muscle tumors have been demonstrated to have estrogen receptor and progesterone receptor immunoreactivity. The estrogen receptor and progesterone receptor immunoreactivity of smooth muscle tumors of the skin has not been reported. We evaluated 15 examples of cutaneous leiomyomas for estrogen receptor and progesterone receptor with ER-1D5 antibody and PGR-1A6 antibody None of the 15 cutaneous leiomyomas demonstrated positive staining by this method. The tumorigenesis of cutaneous leiomyomas does not appear to be related to estrogen or progesterone receptor-mediated effects.

引用

页码：241 / 245

页数：5

共 30 条

[1] ESTROGEN-RECEPTOR ANALYSIS - CORRELATION BETWEEN ENZYME-IMMUNOASSAY AND IMMUNOHISTOCHEMICAL METHODS [J].

AASMUNDSTAD, TA ;

HAUGEN, OA ;

JOHANNESEN, E ;

HOE, AL ;

KVINNSLAND, S .

JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (02) :125-129

[2]

ADAMSON GD, 1992, AM J OBSTET GYNECOL, V166, P746

[3]

BATTIFORA H, 1994, APPL IMMUNOHISTOCHEM, V2, P143

[4] ASSESSMENT OF ANTIGEN DAMAGE IN IMMUNOHISTOCHEMISTRY - THE VIMENTIN INTERNAL CONTROL [J].

BATTIFORA, H .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (05) :669-671

[5]

Battifora H, 1993, APPL IMMUNOHISTO M M, V1, P39

[6] ESTROGEN-RECEPTOR GENE-EXPRESSION IN HUMAN UTERINE LEIOMYOMATA [J].

BRANDON, DD ;

ERICKSON, TE ;

KEENAN, EJ ;

STRAWN, EY ;

NOVY, MJ ;

BURRY, KA ;

WARNER, C ;

CLINTON, GM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (06) :1876-1881

[7] ESTROGEN AND PROGESTERONE-RECEPTOR CONTENT OF ENUCLEATED UTERINE MYOMATA AFTER LUTEINIZING-HORMONE-RELEASING HORMONE - ANALOG DEPOT THERAPY [J].

CIRKEL, U ;

OCHS, H ;

ROEHL, A ;

SCHNEIDER, HPG .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1994, 73 (04) :328-332

[8]

ESTEBAN JM, 1991, MODERN PATHOL, V4, P53

[9]

ESTEBAN JM, 1994, PREDICTIVE VALUE EST, V102, pS9

[10] TOTAL AND UNBOUND CYTOSOLIC ESTROGEN AND PROGESTERONE RECEPTORS IN MYOMETRIUM AND FIBROID AFTER GONADOTROPIN-RELEASING-HORMONE AGONIST TREATMENT [J].

FERNANDEZMONTOLI, ME ;

BALAGUERO, L ;

DIEZGIBERT, O ;

NAVARRO, MA ;

SAMANIEGO, JM .

FERTILITY AND STERILITY, 1995, 63 (03) :522-527

← 1 2 3 →